%20(1).jpg)
Discover the association
PSCC Connect is a non-profit association (French law of 1901) whose mission is to bring together all the economic players contributing to the PSCC and the oncology community. Thanks to its extensive network and regular meetings, PSCC Connect offers players in the PSCC economic ecosystem a platform for convergence, collaboration and co-creation.
The role of PSCC Connect:
-
Represent the PSCC's economic players and gather their needs and ideas,
-
Promote PSCC initiatives within this ecosystem,
-
Facilitate interaction between members.
All players in the economic ecosystem wishing to contribute to innovation in the fight against cancer are welcome to join PSCC Connect. This includes oncology players from start-ups to major corporations, as well as innovation partners such as CROs (Clinical Research Organizations), service and technology companies. We also invite local institutions such as local authorities, competitiveness clusters, incubators, chambers of commerce and, of course, healthcare investors to join us.
+ 150
members
« Join PSCC Connect now and help build what will become a unique community, entirely dedicated to innovation in oncology, whatever the technology. By combining our strengths and dreams, our talents and expertise, doing our best to collaborate and bringing all our energy to bear, we will accelerate innovation in the fight against cancer, for the benefit of patients. »
Christian Deleuze, PSCC Connect President
The association's colleges
Large companies
Bristol Myers Squibb GSK IPSEN J&J Merk Sanofi Servier Takeda Board representatives : Christian Deleuze (Sanofi) Nathalie Depreville (Servier) Catherine George (Ipsen) Philippe Jacquot (Takeda)
SMEs
ABBELIGHT ABCB BIOPHARM ABCELY ADLIN SCIENCE AI4BIO ALGENSCRIBE ALLOY THERAPEUTICS ALTEVAX ANALOGIES APMONIA AQEMIA ARDAN ASQII BLUE BEES BRENUS PHARMA CELEOS CHERRY BIOTECH CURE51 CYTEA BIO EMGLEV E-MIRGENCY ERVIMMUNE EVERIMMUNE EXOSOME ANALYTICS FASTEN GIMLI GIO THERAPEUTICS HEPHAISTOS-PHARMA HIPPOXIS IMAGINOSTICS, INC. INFOCUS INNATE PHARMA INTEGRAGEN INVECTYS JALON THERAPEUTICS MAGIC GENOMIX MCSAF MNEMO THERAPEUTICS MPC THERAPEUTICS MS INSIGHT MUSIC CARE NEOVENTURES BIOTECHNOLOGY EUROPE NK DIAGNOSTICS OCCLUGEL ODIMMA-THERAPEUTICS OKOMERA ON/OF THERAPEUTICS ONCODESIGN PM ONCONANOR > ORINOVA ONCONEX REMUNITY THERAPEUTICS ORAKL ONCOLOGY ORANOMED PEGASCY PEPKON PERSEA PROIMAGING PROMONTORY THERAPEUTICS PROSKOPE PROSTPERIA QALITA QUINTEN HEALTH RESILIENCE ROBEAUTÉ ROSETTA OMICS RD BIOTECH SERENDIP INNOVATIONS SMARTCATCH SURTOUCH LLC TELOMIUM THERANOVIR THERAONCO THERAPANACEA THERASONIC WELL WITH WAVES 3W Board representatives : Stéphanie Cornen (Innate Pharma) Nathalie Donne (Ervimmune) Quentin Lubart (Abbelight) Wahid Awad (Rosetta Omics)
ETI Institutions
CCI Val-De-Marne France Biotech Grand Orly Seine Bièvre Matwin Medicen Établissement public d'aménagement Paris-Saclay PSCC Wilco Board representatives : Etienne Lonchamp (Medicen) Lucia Robert (Matwin)
Research support companies
AFFINISEP AGILENT TECHNOLOGIES ALTER EGO ANTINEO APICES SOLUCIONES AXIOMHEALTH CAPITAL B2G LIFE SCIENCES BIOAGILYTIX BIOGNOSYS BIOPHACT BIOTECHSTUDIO BIOTEM CELL'ECTIV CLINISCIENCE CYTIVA DIVERCHIM ERBC EXPLICYTE FIDAL FIRALIS MOLECULAR PRECISION HMC MATCHING ICOSA IKTOS INITS ILIFE CONSULTING ILLUMINA INFERENTIAL INITS JCBIOCONSULTEU JPT THERAPEUTICS KADANS KEYRUS KYOMED LAB2BIOTECH LAVOIX LIPOMIZE MAXCYTE MEDEXPRIM MISSION BIO NOVAXIA NUVISAN ONCODESIGN SERVICES ONCOFACTORY PAREAN PHINC PL CONSEIL PROMEGA FRANCE RAISING GENE CONSULTING SEQALIS SKEPSOS STILLA TECHNOLOGIES THERAWINGS CONSULTING THERMO FISHER ULTRACE VOXCAN XENTECH Board representatives : Marina Iche (ILife Consulting) Amaury Lachaud (Biognosys)
Investors
Andera Angels Santé BPI France bioqube ventures Jeito Sofinnova parteners GY Ventures Techno Founders Board representatives : Julien Elric (Jeito) Stéphane Loze (Angel Santé)
